a Diabetes Institute, Ohio University, Athens, OH 45701, USA
b Endocrinology Clinic, OhioHealth Castrop Health Center, Athens, OH 45701, USA
c Merck Research Labs, Merck & Co., Inc., 770 Sumneytown Pike, West Point, PA 19486, USA
Patients with type 1 diabetes (T1D) have greater rate and
faster progression of cognitive decline than their age peers.
Its mechanism was directed to microvascular pathway [1].
T1D induces regional microvascular changes in cortical and
subcortical brain structures that are associated with impairment of neurocognitive functions. Microvascular complications, such as diabetic retinopathy, distal symmetric polyneuropathy, and renal complications are each independently
associated with cognitive declines in T1D [1]. Recent evidence suggested that the presence of macrovascular complications and other metabolic factors also independently
contribute to cognitive decline [2].
Insulin resistance (IR) is proposed as the link of type 2
diabetes to cognitive decline. Although IR has also been
quantifed in T1D, it remains unclear if IR is associated
with cognitive decline in T1D. By analyzing the data set
from Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications study
(DCCT/EDIC) study, we test the hypothesis that the cognitive decline occurring in T1D is associated with IR.